Related Experiment Video
Updated: Aug 15, 2026

12:29
Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Recurrent mutation and selection for increased penicillin titre in Aspergillus nidulans
Journal of General Microbiology
|August 1, 1979
Summary
Strain development for increased penicillin production in Aspergillus nidulans was achieved through recurrent mutation and selection. This process resulted in a nearly 300% increase in penicillin titre, demonstrating an effective method for microbial enhancement.
Area of Science:
- Microbiology
- Biotechnology
- Industrial Fermentation
Background:
- Penicillin production is crucial for antibiotic manufacturing.
- Improving microbial strains for higher yields is an ongoing challenge in biotechnology.
- Aspergillus nidulans is a relevant model organism for industrial strain development.
Purpose of the Study:
- To enhance penicillin titre in Aspergillus nidulans strains.
- To evaluate the effectiveness of recurrent mutation and selection for strain improvement.
- To compare two different mutagenesis methods for penicillin yield enhancement.
Main Methods:
- Two selection programs (A and B) were initiated from related Aspergillus nidulans strains.
- Six cycles of mutation and selection were performed.
- Program A used near-ultraviolet light with 8-methoxypsoralen; Program B used ethyl methanesulfonate.
- 100 survivors were assayed for penicillin titre after each cycle, with the top 5 strains selected for the next cycle.
Main Results:
- Both selection programs achieved a near 300% increase in penicillin titre.
- The yield advance was consistent across both mutagenesis strategies.
- The experimental design involving successive cycles of mutagenesis and selection proved effective.
Conclusions:
- Recurrent mutation and selection is a highly effective strategy for strain development in Aspergillus nidulans.
- The chosen mutagenesis and selection methods successfully enhanced penicillin production.
- This study validates a robust experimental design for optimizing microbial yields for industrial applications.
Related Concept Videos
Mismatch Repair
Overview
Antibiotic Selection
Overview
Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...

